Answers are grounded in this paper and cite their sources.
BACKGROUND: Patients with chronic obstructive pulmonary disease (COPD) and idiopathic pulmonary fibrosis (IPF) have reduced pulmonary reserve and increased susceptibility to airborne pollutants. However, practical guidance for managing residential indoor air quality (IAQ) remains limited. Objectives: To review evidence and reference standards relevant to IAQ management in COPD and IPF and propose practical, disease-informed recommendations for reducing indoor pollutant exposure. METHODS: We conducted a focused narrative review of evidence on pollutant exposure, respiratory health effects, and residential exposure-reduction interventions. Domestic and international indoor and ambient air quality standards were reviewed to identify key management parameters and feasible exposure-reduction strategies. Separate decision rules were applied to action references and maintenance targets according to exposure setting, intended use, and source-specific averaging time. RESULTS: Nine parameters were selected: PM2.5, PM10, NO2, CO2, formaldehyde, total volatile organic compounds, CO, O3, and relative humidity. Where applicable, action references indicated conditions under which exposure-reduction measures should be considered, whereas maintenance targets supported routine exposure management. Ambient forecast categories were used only for pollutants primarily managed according to outdoor conditions. CO2 and relative humidity were treated as operational environmental parameters. All values retained the averaging times and intended contexts of their source standards and were not considered disease-specific clinical cutoffs. Recommendations emphasized source control, outdoor air quality-guided ventilation, particle filtration, and control of cooking and combustion emissions. CONCLUSION: This framework provides practical, parameter-specific exposure-management references and strategies for patients with COPD and IPF. Prospective studies should assess whether multicomponent IAQ interventions improve exposure and clinically relevant respiratory outcomes.
No takes yet. Share an insight, caveat, or question.
Shin et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: